S Visonneau

1.2k total citations
35 papers, 999 citations indexed

About

S Visonneau is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, S Visonneau has authored 35 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Oncology and 12 papers in Genetics. Recurrent topics in S Visonneau's work include CAR-T cell therapy research (11 papers), Virus-based gene therapy research (10 papers) and Immunotherapy and Immune Responses (10 papers). S Visonneau is often cited by papers focused on CAR-T cell therapy research (11 papers), Virus-based gene therapy research (10 papers) and Immunotherapy and Immune Responses (10 papers). S Visonneau collaborates with scholars based in United States, France and Italy. S Visonneau's co-authors include D Santoli, Alessandra Cesano, David Kritchevsky, Steven C. Clark, S. A. Tepper, Joseph A. Scimeca, Michael H. Torosian, K. Ann Jeglum, Fabio Malavasi and Silvia Deaglio and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

S Visonneau

34 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Visonneau United States 19 412 341 222 193 128 35 999
Jacki Kornbluth United States 21 763 1.9× 285 0.8× 371 1.7× 51 0.3× 80 0.6× 53 1.3k
Alpha Peled Israel 16 291 0.7× 241 0.7× 286 1.3× 52 0.3× 106 0.8× 50 875
Cissy Geigerman United States 13 251 0.6× 268 0.8× 827 3.7× 255 1.3× 134 1.0× 16 1.4k
NN Tandon United States 10 349 0.8× 129 0.4× 497 2.2× 83 0.4× 120 0.9× 15 1.3k
Daniel Lottaz Switzerland 18 124 0.3× 235 0.7× 437 2.0× 108 0.6× 134 1.0× 26 1.0k
Elias Gounaris United States 18 719 1.7× 411 1.2× 637 2.9× 29 0.2× 127 1.0× 27 1.5k
Oihana Murillo Spain 18 642 1.6× 544 1.6× 313 1.4× 113 0.6× 102 0.8× 26 1.2k
Norma Llansa United States 13 265 0.6× 285 0.8× 534 2.4× 32 0.2× 131 1.0× 15 1.1k
P.A. Bäuerle Germany 5 490 1.2× 248 0.7× 214 1.0× 23 0.1× 53 0.4× 7 815
Nicolas Schrantz United States 15 1.2k 2.9× 315 0.9× 703 3.2× 83 0.4× 62 0.5× 18 1.9k

Countries citing papers authored by S Visonneau

Since Specialization
Citations

This map shows the geographic impact of S Visonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Visonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Visonneau more than expected).

Fields of papers citing papers by S Visonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Visonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Visonneau. The network helps show where S Visonneau may publish in the future.

Co-authorship network of co-authors of S Visonneau

This figure shows the co-authorship network connecting the top 25 collaborators of S Visonneau. A scholar is included among the top collaborators of S Visonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Visonneau. S Visonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Kenneth E., S. Aggarwal, Sharron Gargosky, et al.. (2025). P1097 Phase 1/2 study to assess safety, tolerability, and efficacy of XmAb942 (anti-TL1A) in healthy participants and participants with ulcerative colitis. Journal of Crohn s and Colitis. 19(Supplement_1). i2015–i2015.
2.
Sevestre, Marie‐Antoinette, Jérôme Larghero, Yves Castier, et al.. (2014). Pilot safety study of perivascular injection of tissue-engineered allogeneic aortic endothelial cells in patients undergoing minimally invasive peripheral revascularization. Journal of Vascular Surgery. 59(6). 1597–1606. 3 indexed citations
3.
Geoerger, Birgit, Alessandra Cesano, S Visonneau, et al.. (2000). Antitumor activity of a human cytotoxic T-cell line (TALL-104) in braintumor xenografts. Neuro-Oncology. 2(2). 103–113. 15 indexed citations
4.
Shiue, Chyng‐Yann, et al.. (2000). N-(n-benzylpiperidin-4-yl)-2-[18f]fluorobenzamide: a potential ligand for pet imaging of breast cancer. Nuclear Medicine and Biology. 27(8). 763–767. 17 indexed citations
5.
Visonneau, S, Alessandra Cesano, K. Ann Jeglum, & D Santoli. (1999). Adjuvant treatment of canine osteosarcoma with the human cytotoxic T-cell line TALL-104.. PubMed. 5(7). 1868–75. 25 indexed citations
6.
Cesano, Alessandra, S Visonneau, Thi Tran, & D Santoli. (1999). Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice.. International Journal of Oncology. 14(2). 245–51. 8 indexed citations
7.
Cesano, Alessandra, James Wortman, Michael Pourdehnad, et al.. (1999). Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancer.. International Journal of Oncology. 14(2). 233–44. 4 indexed citations
8.
Cesano, Alessandra, S Visonneau, Silvia Deaglio, Fabio Malavasi, & D Santoli. (1998). Role of CD38 and Its Ligand in the Regulation of MHC-Nonrestricted Cytotoxic T Cells. The Journal of Immunology. 160(3). 1106–1115. 38 indexed citations
9.
Cesano, Alessandra, et al.. (1998). Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice.. PubMed. 18(3A). 1429–34. 136 indexed citations
10.
Cesano, Alessandra, S Visonneau, John H. Wolfe, et al.. (1997). Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104. Cancer Immunology Immunotherapy. 44(3). 125–136. 4 indexed citations
11.
Visonneau, S, Alessandra Cesano, Michael H. Torosian, & D Santoli. (1997). Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice.. PubMed. 3(9). 1491–500. 19 indexed citations
12.
Visonneau, S, Alessandra Cesano, S. A. Tepper, et al.. (1996). Effect of different concentrations of conjugated linoleic acid on tumor cell growth in vitro. The FASEB Journal. 10(3). 182. 7 indexed citations
13.
Cesano, Alessandra, S Visonneau, K. Ann Jeglum, et al.. (1996). Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors.. PubMed. 56(13). 3021–9. 26 indexed citations
14.
Cesano, Alessandra, et al.. (1995). Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T cell clone potentially useful in cancer therapy. Cancer Immunology Immunotherapy. 40(3). 139–151. 9 indexed citations
15.
Visonneau, S, Alessandra Cesano, & D Santoli. (1995). A Revertant TCRγδ+ Cell Clone Which Has Lost MHC Nonrestricted Cytotoxic Activity but Retains Redirected Killing upon Stimulation of the CD3 Receptor. Cellular Immunology. 165(2). 252–265. 3 indexed citations
16.
Cesano, Alessandra, S Visonneau, & D Santoli. (1995). Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line.. PubMed. 55(1). 96–101. 22 indexed citations
17.
Cesano, Alessandra, S Visonneau, L Cioé, et al.. (1994). Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.. Journal of Clinical Investigation. 94(3). 1076–1084. 30 indexed citations
18.
Cesano, Alessandra, S Visonneau, Steven C. Clark, & D Santoli. (1993). Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.. The Journal of Immunology. 151(6). 2943–2957. 80 indexed citations
19.
20.
Khayat, D., C. Soubrane, J.M. Andrieu, et al.. (1990). Changes of Soluble CD16 Levels in Serum of HIV-Infected Patients: Correlation with Clinical and Biologic Prognostic Factors. The Journal of Infectious Diseases. 161(3). 430–435. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacki Kornbluth Breakdown of academic impact, for papers by Alpha Peled Breakdown of academic impact, for papers by Cissy Geigerman Breakdown of academic impact, for papers by NN Tandon Breakdown of academic impact, for papers by Daniel Lottaz Breakdown of academic impact, for papers by Elias Gounaris Breakdown of academic impact, for papers by Oihana Murillo Breakdown of academic impact, for papers by Norma Llansa Breakdown of academic impact, for papers by P.A. Bäuerle Breakdown of academic impact, for papers by Nicolas Schrantz
Rankless by CCL
2026